26 year-old male dies of myocarditis four days after receiving his third booster shot

According to the autopsy report and death certificate obtained by the Defender, for this 26-year-old male "post-Pfizer Covid vaccination myocarditis has been identified to cause left ventricular dysfunction” that led to his death. 

At birth, he was diagnosed with a rare type of blood vessel abnormality inside the brain called Vein of Galen Malformation. This condition could be caused by mutations in RASA1 gene - involved in numerous physiological processes such as angiogenesis, cell proliferation, and apoptosis; regulator of immune B cells TGF-β and EPHB4 involved in cell migration.  He had 13 brain surgeries, endless MRIs, CAT scans, angiograms, pokes, and a final radiation treatment that was a success in eliminating the arteriovenous malformation (AVM).

He got his first and second doses of Pfizer vaccine as soon as his age group was eligible. He did not have any side effects. Almost 7 months later he received his third shot of BNT162b2 vaccine (batch FE3590). It caused some muscle soreness and fatigue. On the fourth day he developed a sore throat. He was feverish and had elevated heart rate. Since this was considered normal according to CDC guidelines no measures - other than Tylenol - were taken. He died in his chair 2 hours after a dinner. Apple watch data show that his heart rate was very high at first, but dropped into the 60s, which was low compared to usual 80s and 90s — and then it just stopped.


REFERENCES

Exclusive: Autopsy Confirms 26-Year-Old’s Death From Myocarditis Directly Caused by Pfizer COVID Vaccine • Children's Health Defense (childrenshealthdefense.org)

Autopsy Reveals Death of 26-Year-Old Man Who Developed Myocarditis was Due to Pfizer Vaccine – DC Weekly

Joseph-G-Keating-age-26-death-certificate-scaled.jpg (1920×2560) (childrenshealthdefense.org)


Comments

Post a Comment

Popular posts from this blog

A New Onset of Ulcerative Colitis post-2nd-breakthrough-COVID-19

Image
A 21-year-old non-smoking Caucasian male with a history of acute pancreatitis but no other medical issues or family history had two doses of the BNT162b2 mRNA COVID-19 vaccine.  Four months after the second dose he had his first episode of COVID-19. Although not hypoxic, he felt pretty unwell for a week, with a severe cough, fever, generalized body ache, headache, and loss of taste. He received the third dose of the vaccine two months after recovering from COVID. Nine months after the third dose, he had the second episode of COVID-19, during which he was mildly unwell for three days, recovered, and did not require any anti-viral medication or antibiotics. One week post the second episode of COVID-19, he developed diarrhea and abdominal pain. It then progressed to bloody diarrhea. Ulcerative colitis was diagnosed based on his clinical symptoms, biopsy changes, and the exclusion of other causes.  There are ten published case reports about the newly diagnosed ulcerative colitis ...
Read more

COVID in May

Image
Concerns about a potential resurgence of COVID-19 are mounting as summer 2024 approaches.  This is driven by several indicators, including social media posts, healthcare data, and wastewater surveillance across different regions. Our study findings corroborate this trend.  While many forecasters anticipate a surge, others expect a gradual increase through the end of May, and then a decline again around early June. Reports from social media suggest emerging clusters of COVID-19 in Texas, several Canadian provinces, the UK, and on cruises in northern regions such as a Norwegian cruise to Alaska.  Data from Alberta's Respiratory virus dashboard   (total weekly laboratory-confirmed COVID-19 cases) and wastewater surveillance in Calgary indicate an uptick in COVID-19 cases starting April 2024. The most recent statistics from Alberta Health reveal a significant increase in hospitalizations due to COVID-19, with 114 individuals currently hospitalized—an incr...
Read more

Chronic SARS-CoV-2 Shedding

Image
Chronic viral shedding, a condition where the virus continues to be released from an individual's body long after the initial infection, has been observed in many infectious diseases, including COVID-19.  In such cases, individuals may remain asymptomatic or experience only mild symptoms while the virus persists. It remains detectable in repeated tests over an extended period and can still infect others even in nasal swab is negative (which happens quite often ). This was evident in our study.    Recent research by Conway et al. (2024) highlights the possibility of chronic SARS-CoV-2 infection, extending over several months and potentially years. Other studies have documented prolonged asymptomatic infections and extended viral shedding in moderate to severe beyond hospital discharge. Analysis of sequencing data on UK samples taken between 2 November 2020 and 15 August 2022 lead to estimates that 0.1–0.5% of infections may become persistent with typically rebounding high ...
Read more